Skip to content

Dilapan-S / Dilasoft E-Registry in Induced Abortion

International Observational E-Registry on the Use of Dilapan-S/Dilasoft Osmotic Dilators for Cervical Priming Prior to Induced Abortion

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02318212
Acronym
DSREGISTRYIA
Enrollment
439
Registered
2014-12-17
Start date
2015-03-31
Completion date
2016-12-31
Last updated
2017-05-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abortion, Induced

Keywords

Cervical dilatation

Brief summary

International Observational E-Registry on the use of osmotic dilators DILAPAN-S® / DILASOFT® for cervical priming prior to induced abortion.

Detailed description

International, multicentre, non-interventional, observational e-registry, post market clinical follow up study to document current clinical use of Dilapan-S or Dilasoft for cervical priming before induced abortion with regard to the number of dilators used, duration of insertion of dilators in situ and unusual complications consequent of their use.

Interventions

DEVICEDilapan-S

Synthetic osmotic dilators Dilapan-S or Dilasoft for cervical priming prior to induced abortion

Sponsors

Medicem International CR s.r.o.
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
No

Inclusion criteria

* Intrauterine pregnancy ≥ 6 and ≤ 24 weeks gestation * Patients who are capable of giving consent and sign the form * Abortion being made in compliance with the Abortion Act 1967 (For England, Wales and Scotland)

Exclusion criteria

* Clinical signs of uterine, vaginal or vulvar infection * Acute bleeding

Design outcomes

Primary

MeasureTime frameDescription
Number of inserted osmotic dilatorsmax. up to 24 hrs; estimated average 6 hrs
Total time taken for cervical priming with Dilapan-S/Dilasoftmax. up to 24 hrs; estimated average 6 hrsDuration of leaving osmotic dilators in situ

Secondary

MeasureTime frameDescription
Other observed undesirable effects uf use of synthetic osmotic dilatorsup to 24 hrs; estimated average 6 hrs
Need of additional mechanical dilationup to 10 minutes after osmotic dilators extractionIn cases, when surgical abortion is performed
Surgical operative timeestimated max. up to 10 min, estimated average 8 min.Period from speculum insertion in to speculum extraction out
Type of synthetic osmotic dilator usedmax. up to 24 hrs; estimated average 6 hrsDilapan-S or Dilasoft
Induction-to-delivery timeup to 72 hrs; estimated average 48 hrsIn case of medical abortion
Complications related to induced abortion procedureup to 24 hrs; estimated average 12 hrs
Infectious complication and its relation to the use of Dilapan-S/Dilasoftup to 72 hrs; Complications, if any, will be followed-up until stable situation has been reached.
Initiation-to-delivery timehrsIn case of medical abortion
Complications during cervical primingup to 24 hrs; estimated average 6 hrspre-operative bleeding, fever, pain, nausea, vomiting, diarrhoea, premature passage of foetal or chorionic tissue

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026